Green Cross Holdings Corporation (005250.KS)
KRW 13700.0
(1.11%)
KRW 13700.0
(1.11%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1105.62 Billion KRW | 44.77% |
| 2022 | 763.68 Billion KRW | 28.91% |
| 2021 | 592.42 Billion KRW | 16.18% |
| 2020 | 509.91 Billion KRW | -24.89% |
| 2019 | 678.92 Billion KRW | 25.34% |
| 2018 | 541.67 Billion KRW | 28.12% |
| 2017 | 422.79 Billion KRW | 12.01% |
| 2016 | 377.44 Billion KRW | 115.98% |
| 2015 | 174.75 Billion KRW | -15.73% |
| 2014 | 207.38 Billion KRW | 31.78% |
| 2013 | 157.37 Billion KRW | 18.08% |
| 2012 | 133.28 Billion KRW | -55.7% |
| 2011 | 300.88 Billion KRW | 1251.75% |
| 2010 | -26.12 Billion KRW | -141.13% |
| 2009 | 63.52 Billion KRW | -66.8% |
| 2008 | 191.3 Billion KRW | 188.42% |
| 2007 | 66.32 Billion KRW | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1322.58 Billion KRW | 6.67% |
| 2024 Q1 | 1239.89 Billion KRW | 12.14% |
| 2023 Q2 | 948.97 Billion KRW | -7.17% |
| 2023 FY | 1105.62 Billion KRW | 44.77% |
| 2023 Q3 | 1178.24 Billion KRW | 24.16% |
| 2023 Q4 | 1105.62 Billion KRW | -6.16% |
| 2023 Q1 | 1022.26 Billion KRW | 33.86% |
| 2022 Q4 | 763.68 Billion KRW | -3.25% |
| 2022 Q2 | 722.77 Billion KRW | 27.48% |
| 2022 FY | 763.68 Billion KRW | 28.91% |
| 2022 Q1 | 566.95 Billion KRW | -4.3% |
| 2022 Q3 | 789.33 Billion KRW | 9.21% |
| 2021 Q3 | 639.15 Billion KRW | 3.99% |
| 2021 Q2 | 614.64 Billion KRW | 12.22% |
| 2021 Q4 | 592.42 Billion KRW | -7.31% |
| 2021 FY | 592.42 Billion KRW | 16.18% |
| 2021 Q1 | 547.72 Billion KRW | 7.42% |
| 2020 FY | 509.91 Billion KRW | -24.89% |
| 2020 Q4 | 509.91 Billion KRW | -27.23% |
| 2020 Q2 | 1051.47 Billion KRW | 37.83% |
| 2020 Q1 | 762.89 Billion KRW | 12.37% |
| 2020 Q3 | 700.72 Billion KRW | -33.36% |
| 2019 Q4 | 678.92 Billion KRW | 2.26% |
| 2019 FY | 678.92 Billion KRW | 25.34% |
| 2019 Q1 | 597.07 Billion KRW | 10.23% |
| 2019 Q2 | 608.33 Billion KRW | 1.89% |
| 2019 Q3 | 663.93 Billion KRW | 9.14% |
| 2018 Q2 | 568.16 Billion KRW | 14.2% |
| 2018 Q1 | 497.52 Billion KRW | 17.68% |
| 2018 FY | 541.67 Billion KRW | 28.12% |
| 2018 Q4 | 541.67 Billion KRW | -14.9% |
| 2018 Q3 | 636.53 Billion KRW | 12.03% |
| 2017 Q4 | 422.79 Billion KRW | 4.03% |
| 2017 Q2 | 376.2 Billion KRW | 1.96% |
| 2017 Q1 | 368.98 Billion KRW | -2.24% |
| 2017 FY | 422.79 Billion KRW | 12.01% |
| 2017 Q3 | 406.4 Billion KRW | 8.03% |
| 2016 Q4 | 377.44 Billion KRW | -9.2% |
| 2016 Q3 | 415.69 Billion KRW | 6.09% |
| 2016 Q2 | 391.82 Billion KRW | 14.07% |
| 2016 Q1 | 343.49 Billion KRW | 96.55% |
| 2016 FY | 377.44 Billion KRW | 115.98% |
| 2015 FY | 174.75 Billion KRW | -15.73% |
| 2015 Q1 | 288.98 Billion KRW | 39.34% |
| 2015 Q2 | 295.01 Billion KRW | 2.09% |
| 2015 Q3 | 237.07 Billion KRW | -19.64% |
| 2015 Q4 | 174.75 Billion KRW | -26.28% |
| 2014 Q4 | 207.38 Billion KRW | -3.86% |
| 2014 Q3 | 215.71 Billion KRW | -14.08% |
| 2014 Q2 | 251.07 Billion KRW | 14.49% |
| 2014 Q1 | 219.29 Billion KRW | 39.34% |
| 2014 FY | 207.38 Billion KRW | 31.78% |
| 2013 FY | 157.37 Billion KRW | 18.08% |
| 2013 Q1 | 117.36 Billion KRW | -11.94% |
| 2013 Q2 | 109.91 Billion KRW | -6.35% |
| 2013 Q3 | 144.14 Billion KRW | 31.15% |
| 2013 Q4 | 157.37 Billion KRW | 9.18% |
| 2012 FY | 133.28 Billion KRW | -55.7% |
| 2012 Q3 | 137.11 Billion KRW | 14.88% |
| 2012 Q4 | 133.28 Billion KRW | -2.8% |
| 2012 Q1 | 69.36 Billion KRW | -76.95% |
| 2012 Q2 | 119.35 Billion KRW | 72.07% |
| 2011 FY | 300.88 Billion KRW | 1251.75% |
| 2011 Q4 | 300.88 Billion KRW | 125.8% |
| 2011 Q3 | 133.25 Billion KRW | -6.87% |
| 2011 Q2 | 143.08 Billion KRW | -24.84% |
| 2011 Q1 | 190.37 Billion KRW | 0.0% |
| 2010 Q3 | 156.94 Billion KRW | 26.38% |
| 2010 FY | -26.12 Billion KRW | -141.13% |
| 2010 Q1 | 73.91 Billion KRW | 0.0% |
| 2010 Q2 | 124.18 Billion KRW | 68.0% |
| 2009 FY | 63.52 Billion KRW | -66.8% |
| 2009 Q3 | 51.8 Billion KRW | -30.77% |
| 2009 Q2 | 74.84 Billion KRW | 4.25% |
| 2009 Q1 | 71.78 Billion KRW | 0.0% |
| 2008 Q2 | 57.76 Billion KRW | -7.27% |
| 2008 Q3 | 52.74 Billion KRW | -8.68% |
| 2008 FY | 191.3 Billion KRW | 188.42% |
| 2008 Q1 | 62.28 Billion KRW | 0.0% |
| 2007 FY | 66.32 Billion KRW | 0.0% |
| 2007 Q1 | 107.96 Billion KRW | 0.0% |
| 2007 Q2 | 100.62 Billion KRW | -6.8% |
| 2007 Q3 | 79.54 Billion KRW | -20.95% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| ORIENT BIO Inc. | -3.06 Billion KRW | 36122.943% |
| Green Cross Holdings Corporation | 674.31 Billion KRW | -63.963% |
| Pharmicell Co., Ltd. | -10.69 Billion KRW | 10436.502% |
| Green Cross Corporation | 674.31 Billion KRW | -63.963% |
| GeneOne Life Science, Inc. | 8.04 Billion KRW | -13636.618% |
| Celltrion, Inc. | 1325.8 Billion KRW | 16.607% |
| Samsung Biologics Co.,Ltd. | 1541.39 Billion KRW | 28.271% |
| SK bioscience Co.,Ltd. | -106.45 Billion KRW | 1138.616% |
| SK Biopharmaceuticals Co., Ltd. | -61.64 Billion KRW | 1893.396% |
| Prestige BioPharma Limited | -129.76 Billion KRW | 952.016% |